Drug Pipeline

Tivozanib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
1
Phase 3
4
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT06661720
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab)…		 Trial sites expanded: 410 -> 414 locations
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06661720 Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab)… Clear Cell Renal Cell Carcinoma Recruiting
Phase 2
NCT06053658 Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal… Renal Cell Carcinoma Recruiting
Phase 1/2
NCT04645160 Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers Cholangiocarcinoma Recruiting
NCT05000294 Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types Bile Duct Cancer Recruiting
Sponsors Running Tivozanib Trials
National Cancer Institute (NCI) (1) University of Florida (1) M.D. Anderson Cancer Center (1) Alliance for Clinical Trials in Oncology (1)
Disease Areas
Cholangiocarcinoma (2) Kidney Cancer (2) Breast Cancer (1) Prostate Cancer (1) Bladder Cancer (1) Ovarian Cancer (1) Sarcoma (1)
Get alerts when Tivozanib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free